A. A grantee shall execute a grant agreement or loan agreement with the Corporation, in a form prescribed by the Corporation, that:
- (1) Makes disbursement of financial assistance contingent on evidence of IRB approval of the State-funded stem cell research described in the application;
- (2) Acknowledges, as appropriate, that an award of financial assistance beyond the current fiscal year may be contingent on future appropriations to the Fund;
- (3) Establishes the scope of the State's ownership or other financial interest in the commercialization and other benefits of the results, products, inventions, and discoveries of the State-funded stem cell research described in the application;
- (4) Discusses, as appropriate, other matters related to intellectual property; and
- (5) Contains other assurances, as determined by the Corporation, related to the grantee's compliance with applicable law and the terms of the financial assistance.
- B. A grantee shall, upon request, provide information to the Commission and Corporation reasonably related to the oversight of an award of financial assistance and the progress and results of the State-funded stem cell research.
Authority: Economic Development Article, §10-409 and 10-441, Annotated Code of Maryland
Effective date: August 27, 2007 (34:17 Md. R. 1510)
Regulations .01—.11 under COMAR 14.04.01, Stem Cell Research Commission recodified to be COMAR 14.04.08, Stem Cell Research Commission effective December 30, 2019 (46:26 Md. R. 1167)
Regulation .03B amended effective February 22, 2021 (48:4 Md. R. 178)
Regulation .05A amended effective February 22, 2021 (48:4 Md. R. 178)